Good_老虎社区_美港股上老虎

Gowithflow
2021-12-07

Good

Biden targets drug makers, urges swift Senate vote on price reform

WASHINGTON, Dec 6 (Reuters) - President Joe Biden took aim on Monday at pharmaceutical companies he

Biden targets drug makers, urges swift Senate vote on price reform

免责声明：上述内容仅代表发帖人个人观点，不构成本平台的任何投资建议。

推荐
最新

暂无评论

热议股票

关于我们·老虎社区守则·老虎社区账号管理规范·老虎社区服务协议·老虎社区隐私政策

公司名称：北京至简风宜信息技术有限公司

违法和不良信息投诉：010-5681-3562（工作时间9:30-18:30）

邮箱：service@laohu8.com

营业执照：91110105MA01A4U55R

ICP备：京ICP备18016422号

网安备：京公网安备11010502036490

关注我们

{"i18n":{"language":"zh_CN"},"data":{"magic":2,"id":606352747,"tweetId":"606352747","gmtCreate":1638837626197,"gmtModify":1638837626197,"author":{"id":3581675070172532,"idStr":"3581675070172532","authorId":3581675070172532,"authorIdStr":"3581675070172532","name":"Gowithflow","avatar":"https://static.tigerbbs.com/9955c41d29e26233988fd4c79052a8b0","vip":1,"userType":1,"introduction":"","boolIsFan":false,"boolIsHead":false,"crmLevel":3,"crmLevelSwitch":0,"individualDisplayBadges":[],"fanSize":1,"starInvestorFlag":false},"themes":[],"images":[],"coverImages":[],"extraTitle":"","html":"<html><head></head><body><p>Good</p></body></html>","htmlText":"<html><head></head><body><p>Good</p></body></html>","text":"Good","highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"favoriteSize":0,"link":"https://laohu8.com/post/606352747","repostId":2189868982,"repostType":4,"repost":{"id":"2189868982","kind":"highlight","weMediaInfo":{"introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"media_name":"Reuters","id":"1036604489","head_image":"https://static.tigerbbs.com/443ce19704621c837795676028cec868"},"pubTimestamp":1638836760,"share":"https://www.laohu8.com/m/news/2189868982?lang=&edition=full","pubTime":"2021-12-07 08:26","market":"us","language":"en","title":"Biden targets drug makers, urges swift Senate vote on price reform","url":"https://stock-news.laohu8.com/highlight/detail?id=2189868982","media":"Reuters","summary":"WASHINGTON, Dec 6 (Reuters) - President Joe Biden took aim on Monday at pharmaceutical companies he ","content":"<p>WASHINGTON, Dec 6 (Reuters) - President Joe Biden took aim on Monday at pharmaceutical companies he said were unjustifiably raising drug prices and urged Congress to pass his landmark Build Back Better bill to lower costs for everyday Americans.</p>\n<p>The United States spends more than twice as much per person on drugs as other wealthy economies. One in four Americans who take prescription drugs struggles to afford them.</p>\n<p>\"These price increase are about companies looking to maximize profits, and nobody is standing up for the patients,\" Biden said at the White House, after meeting two diabetic patients who spoke about their struggles to pay for insulin. \"It's enough, enough.\"</p>\n<p>Biden and his fellow Democrats promised voters sweeping drug price reform in their signature social spending bill, but agreed to move ahead with a far less ambitious proposal&nbsp;after facing opposition from centrist dissenters in Congress.</p>\n<p>The House of Representative has passed the bill, which has a drug pricing provision that among other things sets a $35 monthly cap on insulin prices.</p>\n<p>Biden called on the Senate to follow suit on Monday.</p>\n<p>A bottle of insulin costs less than $10 to make, Biden said, yet in the U.S. a monthly supply costs about $375 on average and can go as high as $1,000. Insulin prices have gone up by 15% or more in some cases over the past decade, he said.</p>\n<p>\"Should I buy groceries, or my insulin and other necessary supplies related to diabetes? I had to make this choice relentlessly, without relief, every day\" explained Iesha Meza, who was diagnosed with type 1 diabetes at age 21, and who spoke at the White House before Biden.</p>\n<p>\"I was forced to ration my supply of a drug that is as vital to me as water,\" she said. \"I felt myself growing weaker and weaker each day.\" She ended up being rushed to a hospital and slipping into a life-threatening diabetic coma.</p>\n<p>Biden stressed that drugmakers should make profits and get a \"fair return\" on investments. \"Right now drug companies have set the price at whatever the market will bear,\" he said.</p>\n<p>Insulin is made largely by three companies: Eli Lilly and Co, Novo Nordisk A/S&nbsp;and <a href=\"https://laohu8.com/S/GCVRZ\">Sanofi</a> SA</p>\n<p>Many of the millions of U.S. diabetics have struggled during the COVID-19 pandemic to access regular testing and maintenance to handle the disease, a Reuters investigation found.</p>\n<p>The $35 cap, which does not apply for those without health insurance, does not cut insulin prices, instead subsidizing customers with tax dollars.</p>\n<p>Drugmakers say the proposal would undermine their ability to develop new medicines, though insulin was discovered a century ago. A congressional report</p>\n<p>showed that top drugmakers have spent around $50 billion more on share buybacks and dividends than research and development between 2016 and 2020.</p>\n<p>The bill will reduce access to treatment and stifle the development of new uses and improvements to medicines, PhRMA, the industry's largest U.S. trade group, said in a statement shortly following Biden's remarks.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Biden targets drug makers, urges swift Senate vote on price reform</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nBiden targets drug makers, urges swift Senate vote on price reform\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1036604489\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/443ce19704621c837795676028cec868);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Reuters </p>\n<p class=\"h-time\">2021-12-07 08:26</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>WASHINGTON, Dec 6 (Reuters) - President Joe Biden took aim on Monday at pharmaceutical companies he said were unjustifiably raising drug prices and urged Congress to pass his landmark Build Back Better bill to lower costs for everyday Americans.</p>\n<p>The United States spends more than twice as much per person on drugs as other wealthy economies. One in four Americans who take prescription drugs struggles to afford them.</p>\n<p>\"These price increase are about companies looking to maximize profits, and nobody is standing up for the patients,\" Biden said at the White House, after meeting two diabetic patients who spoke about their struggles to pay for insulin. \"It's enough, enough.\"</p>\n<p>Biden and his fellow Democrats promised voters sweeping drug price reform in their signature social spending bill, but agreed to move ahead with a far less ambitious proposal&nbsp;after facing opposition from centrist dissenters in Congress.</p>\n<p>The House of Representative has passed the bill, which has a drug pricing provision that among other things sets a $35 monthly cap on insulin prices.</p>\n<p>Biden called on the Senate to follow suit on Monday.</p>\n<p>A bottle of insulin costs less than $10 to make, Biden said, yet in the U.S. a monthly supply costs about $375 on average and can go as high as $1,000. Insulin prices have gone up by 15% or more in some cases over the past decade, he said.</p>\n<p>\"Should I buy groceries, or my insulin and other necessary supplies related to diabetes? I had to make this choice relentlessly, without relief, every day\" explained Iesha Meza, who was diagnosed with type 1 diabetes at age 21, and who spoke at the White House before Biden.</p>\n<p>\"I was forced to ration my supply of a drug that is as vital to me as water,\" she said. \"I felt myself growing weaker and weaker each day.\" She ended up being rushed to a hospital and slipping into a life-threatening diabetic coma.</p>\n<p>Biden stressed that drugmakers should make profits and get a \"fair return\" on investments. \"Right now drug companies have set the price at whatever the market will bear,\" he said.</p>\n<p>Insulin is made largely by three companies: Eli Lilly and Co, Novo Nordisk A/S&nbsp;and <a href=\"https://laohu8.com/S/GCVRZ\">Sanofi</a> SA</p>\n<p>Many of the millions of U.S. diabetics have struggled during the COVID-19 pandemic to access regular testing and maintenance to handle the disease, a Reuters investigation found.</p>\n<p>The $35 cap, which does not apply for those without health insurance, does not cut insulin prices, instead subsidizing customers with tax dollars.</p>\n<p>Drugmakers say the proposal would undermine their ability to develop new medicines, though insulin was discovered a century ago. A congressional report</p>\n<p>showed that top drugmakers have spent around $50 billion more on share buybacks and dividends than research and development between 2016 and 2020.</p>\n<p>The bill will reduce access to treatment and stifle the development of new uses and improvements to medicines, PhRMA, the industry's largest U.S. trade group, said in a statement shortly following Biden's remarks.</p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"NVO":"诺和诺德","LLY":"礼来","GCVRZ":"Sanofi"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2189868982","content_text":"WASHINGTON, Dec 6 (Reuters) - President Joe Biden took aim on Monday at pharmaceutical companies he said were unjustifiably raising drug prices and urged Congress to pass his landmark Build Back Better bill to lower costs for everyday Americans.\nThe United States spends more than twice as much per person on drugs as other wealthy economies. One in four Americans who take prescription drugs struggles to afford them.\n\"These price increase are about companies looking to maximize profits, and nobody is standing up for the patients,\" Biden said at the White House, after meeting two diabetic patients who spoke about their struggles to pay for insulin. \"It's enough, enough.\"\nBiden and his fellow Democrats promised voters sweeping drug price reform in their signature social spending bill, but agreed to move ahead with a far less ambitious proposal after facing opposition from centrist dissenters in Congress.\nThe House of Representative has passed the bill, which has a drug pricing provision that among other things sets a $35 monthly cap on insulin prices.\nBiden called on the Senate to follow suit on Monday.\nA bottle of insulin costs less than $10 to make, Biden said, yet in the U.S. a monthly supply costs about $375 on average and can go as high as $1,000. Insulin prices have gone up by 15% or more in some cases over the past decade, he said.\n\"Should I buy groceries, or my insulin and other necessary supplies related to diabetes? I had to make this choice relentlessly, without relief, every day\" explained Iesha Meza, who was diagnosed with type 1 diabetes at age 21, and who spoke at the White House before Biden.\n\"I was forced to ration my supply of a drug that is as vital to me as water,\" she said. \"I felt myself growing weaker and weaker each day.\" She ended up being rushed to a hospital and slipping into a life-threatening diabetic coma.\nBiden stressed that drugmakers should make profits and get a \"fair return\" on investments. \"Right now drug companies have set the price at whatever the market will bear,\" he said.\nInsulin is made largely by three companies: Eli Lilly and Co, Novo Nordisk A/S and Sanofi SA\nMany of the millions of U.S. diabetics have struggled during the COVID-19 pandemic to access regular testing and maintenance to handle the disease, a Reuters investigation found.\nThe $35 cap, which does not apply for those without health insurance, does not cut insulin prices, instead subsidizing customers with tax dollars.\nDrugmakers say the proposal would undermine their ability to develop new medicines, though insulin was discovered a century ago. A congressional report\nshowed that top drugmakers have spent around $50 billion more on share buybacks and dividends than research and development between 2016 and 2020.\nThe bill will reduce access to treatment and stifle the development of new uses and improvements to medicines, PhRMA, the industry's largest U.S. trade group, said in a statement shortly following Biden's remarks.","news_type":1},"isVote":1,"tweetType":1,"viewCount":790,"commentLimit":10,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"symbols":[],"verified":2,"subType":0,"readableState":1,"langContent":"CN","currentLanguage":"CN","warmUpFlag":false,"orderFlag":false,"shareable":true,"causeOfNotShareable":"","featuresForAnalytics":[],"commentAndTweetFlag":false,"andRepostAutoSelectedFlag":false,"upFlag":false,"length":4,"xxTargetLangEnum":"ZH_CN"},"commentList":[],"hasMoreComment":false,"orderType":2}